Birla Institute of Technology, Mesra
Faculty Image

Dr. Pran Kishore Deb

Joined Institute on : 2-Aug-2023

  • Assistant Professor
  • Pharmaceutical Sciences and Tech
  • PhD
Contact Address

Department of Pharmaceutical Sciences and Technology, BIT Mesra, Ranchi, 835215, Jharkhand, India

Quarter No. CII/38, Outer Campus, BIT Mesra, Ranchi 835215, Jharkhand

  • Phone Office - 8822667507
  • Phone Residence - 8822667507
  • Email - prankishore1@gmail.com
Work Experience

Teaching : 12 Years

Research : 10 Years

Individual: 12 Years
Professional Background
  • Ph.D. in Pharmacy (2013), UIPS, Panjab University, Chandigarh, India
  • Master of Pharmacy (2006), Pharmaceutical Medicinal Chemistry, PES College of Pharmacy, Rajiv Gandhi University of Health Sciences (RGUHS), Bangalore, India
  • Bachelor of Pharmacy (2002), PES College of Pharmacy, RGUHS, Bangalore, India
Research Areas

Design, Synthesis, and Development of Novel Chemical Entities (NCEs) targeting Adenosine Receptors, TB, Inflammation and Cancer.
Award and Honours
  • Recognition - World Top 2% Scientists (Single Year Category 2020-2023): Compiled and Enlisted by Stanford University, published by the Elsevier Database https://elsevier.digitalcommonsdata.com/datasets/compare/btchxktzyw 
  • APP’s Innovative Researcher Award 2019. Awarded by “Association of Pharmacy Professionals (APP)” at APP 1st Indo-Jordan Conference, “Global Trends in Drug Design, Discovery, and Pharmaceutical Sciences”, School of Pharmaceutical Sciences, VELS University, 23/7/2019, Chennai, Tamilnadu, India
  • First prize-IMU Best Faculty Achievement Award under e-Learning Innovation. March 13, 2015, International Medical University (IMU), Kuala Lumpur, Malaysia.
  • Best Oral Presentation Award for the project entitled “WOWLA - Working Group Online Workshops, Lectures and Assessments (IR05)" at “International Medical Education Conference (IMEC)” April 22-24, 2015, International Medical University (IMU), Kuala Lumpur, Malaysia.
  • Best Poster Award for poster presentation on “In silico Pharmacophore Elucidation for Bicyclic Antagonists of the Human A3 Adenosine Receptor and its comparison with A2A adenosine receptor bicyclic antagonists”. 12th MPS Pharmacy Scientific Conference 2015, November 13–15, 2015, Tylor’s University Lakeside Campus, Subang Jaya, Malaysia, Abstract No. PCP02 (MPSPSC2015000151), Malaysian Journal of Pharmacy Vol2, Issue 1, p-147, November 2015.
  • E-Learning GURU Award, 2014, International Medical University (IMU), Kuala Lumpur, Malaysia, November 10, 2014.
  • Third prize-IMU Best Faculty Achievement Award under e-Learning Innovation for the project entitled “Online Training of Post Graduate Students on Computer Aided Drug Design” April 11, 2014, International Medical University (IMU), Kuala Lumpur, Malaysia.
  • Achievement Award for developing a new program and successfully launching Master of Science in Analytical & Pharmaceutical Chemistry (MAPC), 2013, International Medical University (IMU), Kuala Lumpur, Malaysia.
  • Foreign Travel Grant Award by the Department of Science and Technology (DST), New Delhi, India, for attending and presenting our research work at the 243rd ACS National Meeting & Exposition, organized by American Chemical Society (ACS), San Diego, California, USA, March 25-29, 2012.
  • Foreign Travel Grant Award by Council of Scientific and Industrial Research (CSIR), New Delhi, India, for attending and presenting our research work at the International Symposium on Challenges in Organic Chemistry and Chemical Biology (ISACS1), organized by the Royal Society of Chemistry (RSC), San Francisco, USA, July 6-9, 2010.
  • Best Oral Presentation Award for oral presentation on “Design, synthesis and in-vitro adenosine A1, A2A, A2B, A3 receptor binding studies and in-vivo anti-inflammatory evaluation of some novel hetero-fused thienopyrimidines”, at international symposium “Recent Advances in Pharmaceutical Science: Transferring Knowledge from Education to Practice,” Katmandu University, Nepal from the Feb 25-27, 2012.
  • Best Poster Award for poster presentation on Design, synthesis, and evaluation of some novel hetero-fused pyrimidines as possible adenosine receptor antagonists. AICTE-sponsored “National Seminar on Recent Trends in Pharmaceutical Research,” MMCP, MMU, Ambala, (Abstract No. PC-147), August 7-8, 2010.
  • Achieved Gold medal in the 1st year and 2nd year M. Pharm. for being an academic topper from PES College of Pharmacy, and securing Fifth rank from the Rajib Gandhi University of Health Sciences (RGUHS) Bangalore, India 2005-2006. 
  • Honoured as Child Scientist for participating in National Level Competition held by “National Children Science Congress” 1996, Guwahati, India.

 
Publications

RESEARCH PAPERS: (*Corresponding author)

  1. Nagdeve, Rahul D., Jyoti Swarup Thakur, Sandeep Chandrashekharappa, Keshab M. Bairagi, Pran Kishore Deb, Katharigatta N. Venugopala, Pradip Kumar Mondal, Maurizio Polentarutti, Osama I Alwassil, Viresh Mohanlall, Susanta K Nayak. "Crystal Structure, Hydrogen bonding interactions, Hirshfeld surfaces, Energy frameworks, and DFT calculation of Diethyl 3-(4-substitutedbenzoyl)indolizine-1,2-dicarboxylates." Journal of Molecular Structure, 2024, 138080.
  2. Shende, Sondarya Uttam, Nizar A. Al-Shar’i, Surbhi Mahender Saini, Viresh Mohanlall, Raquel M. Gleiser, Pran Kishore Deb, Mohamed A. Morsy, Katharigatta N. Venugopala, and Sandeep Chandrashekharappa. "Synthesis, characterization and larvicidal studies of ethyl 3-benzoyl-7-(piperidin-1-yl) indolizine-1-carboxylate analogues against Anopheles arabiensis and cheminformatics approaches." Journal of Biomolecular Structure and Dynamics, 2024, 1-13.
  3. Dahabiyeh, Lina A., Farah Hudaib, Wafa Hourani, Wesam Darwish, Bashaer Abu-Irmaileh, Pran Kishore Deb, Katharigatta N. Venugopala et al. "Mass Spectrometry-based Metabolomics Approach and in vitro Assays Revealed Promising Role of 2,3-Dihydroquinazolin-4(1H)-one Derivatives Against Colorectal Cancer Cell Lines." European Journal of Pharmaceutical Sciences. 2023; 106378.
  4. Duraisamy, R., Al-Shar’i, N.A., Chandrashekharappa, S., Deb, Pran Kishore, Gleiser, R.M., Tratrat, C., Chopra, D., Muthukurpalya Bhojegowd, M.R., Thirumalai, D., Morsy, M.A., Ibrahim, Y.F. Synthesis, biological evaluation, and computational investigation of ethyl 2,4,6-trisubstituted-1,4-dihydropyrimidine-5-carboxylates as potential larvicidal agents against Anopheles arabiensis. Journal of Biomolecular Structure and Dynamics, 2023, 1-13.
  5. Dahabiyeh, Lina A., Wafa Hourani, Wesam Darwish, Farah Hudaib, Bashaer Abu-Irmaileh, Pran Kishore Deb, Katharigatta N. Venugopala, Mohanlall V, Abu-Dahab R, Semreen MH, Bustanji Y. Molecular and metabolic alterations of 2, 3-dihydroquinazolin-4-(1H)-one derivatives in prostate cancer cell lines. Scientific Reports. 2022; 12(1), 1-17.
  6. Venugopala, Katharigatta N., Nizar A. Al-Shar’i, Lina A. Dahabiyeh, Wafa Hourani, Pran Kishore Deb*, Pillay M, Melendhran Pillay, et al. Antitubercular, Cytotoxicity, and Computational Target Validation of Dihydroquinazolinone Derivatives. Antibiotics. 2022; 11(7):831.
  7. Venugopala, Katharigatta N., Pottathil Shinu, Christophe Tratrat, Pran Kishore Deb*, Raquel M. Gleiser, Sandeep Chandrashekharappa, Deepak Chopra et al. 1,2,3-Triazolyl-tetrahydropyrimidine Conjugates as Potential Sterol Carrier Protein-2 Inhibitors: Larvicidal Activity against the Malaria Vector Anopheles arabiensis and In Silico Molecular Docking Study. Molecules, 2022, 27(9), 2676.
  8. Attimarad, Mahesh, Muhammad Shahzad Chohan, Venugopala Katharigatta Narayanaswamy, Anroop Balachandran Nair, N. Sreeharsha, Sheeba Shafi, Marysheela David, Abdulmalek Ahmed Balgoname,1 Abdulrahman Ibrahim Altaysan,1 Efren II Plaza Molina,6 and Pran Kishore Deb. Mathematically Processed UV Spectroscopic Method for Quantification of Chlorthalidone and Azelnidipine in Bulk and Formulation: Evaluation of Greenness and Whiteness. Journal of Spectroscopy 2022, 4965138.
  9. Attimarad, Mahesh, Katharigatta Narayanaswamy Venugopala, Anroop Balachandran Nair, Sreeharsha Nagaraja, Effren II Plaza Molina, Ramling Bhagavantrao Kotnal, Christophe Tratrat, Abdulrahman Ibrahim Altaysan, Abdulmalek Ahmed Balgoname, and Pran Kishore Deb. Environmental Sustainable mathematically processed UV spectroscopic methods for quality control analysis of remogliflozin and teneligliptin: Evaluation of greenness and whiteness. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2022, 278(5), 121303.
  10. Attimarad M, Venugopala KN, Nair AB, Sreeharsha N, Pran Kishore Deb. Experimental Design Approach for Quantitative Expressions of Simultaneous Quantification of Two Binary Formulations Containing Remogliflozin and Gliptins by RP-HPLC. Separations. 2022; 9(2):23.
  11. Pran Kishore Deb*, Katharigatta N. Venugopala, Nizar A. Al-Shar’i, Melendhran Pillay, Pobitra Borah. In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies of substituted 1,2,4-oxadiazole analogues against Mycobacterium tuberculosis. Journal of Enzyme Inhibition and Medicinal Chemistry. 2021, 36 (1), 869-884.
  12. Venugopala, Katharigatta N., Sandeep Chandrashekharappa, Pran Kishore Deb*, Christophe Tratrat, Melendhran Pillay, Deepak Chopra, Nizar A. Al-Shar’i et al. "Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme." Journal of enzyme inhibition and medicinal chemistry. 2021, 36(1), 1472-1487.
  13. Shun Ying Quah, Charng Choon Wong, Hui Chyn Wong, Kok Lian Ho, Nizar Abdul Manan, Pran Kishore Deb, Sreenivasa Rao Sagineedu, Johnson Stanslas. Microarray-based identification of differentially expressed genes associated with andrographolide derivatives-induced resistance in colon and prostate Cancer cell lines. Toxicology and Applied Pharmacology, 2021, 425, 115605.
  14. Venugopala, Katharigatta N., Pran Kishore Deb*, Melendhran Pillay, Deepak Chopra, Sandeep Chandrashekharappa, Mohamed A. Morsy, Bandar E. Aldhubiab, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Mahmoud Kandeel, Rashmi Venugopala and Viresh Mohanlall. 4-Aryl-1,4-Dihydropyridines as Potential Enoyl-Acyl Carrier Protein Reductase Inhibitors: Antitubercular Activity and Molecular Docking Study. Current Topics in Medicinal Chemistry 2021, 21(4): 295-306.
  15. Katharigatta N Venugopala, Sandeep Chandrashekharappa, Christophe Tratrat, Pran Kishore Deb, Rahul D Nagdeve, et al. Molecular Modeling, and COX-2 Inhibition Studies on Indolizine Derivatives. Molecules, 2021, 2612, 3550.
  16. Al-Jaidi, Bilal A., Soha Taher Telfah, Sanaa K. Bardaweel, Pran Kishore Deb*, Pobitra Borah, Katharigatta N. Venugopala, Yazan A. Bataineh, and Q. A. Al Khames Aga. "Anticancer Activity and In silico ADMET Properties of 2,4,5-Trisubstitutedthiazole Derivatives." Current Drug Metabolism, 2021, 22(7), 532-536.
  17. Shun Ying Quah, Michelle Siying Tan, Kok Lian Ho, Nizar Abdul Manan, Alemayehu Abebe Gorfe, Pran Kishore Deb, Sreenivasa Rao Sagineedu, Johnson Stanslas. In silico and saturation transfer difference NMR approaches to unravel the binding mode of an andrographolide derivative to K-Ras oncoprotein (vol 12, pg 1611, 2020). Future Medicinal Chemistry, 2020, 12(20), 1885-1885.
  18. Al-Jaidi, Bilal A., Pran Kishore D.*, Soha Taher T., Abdel Naser D., Yazan A. B., Qutaiba Ahmed Al Khames Aga, Mohammad A. Al-Dhoun, Ala’ Ali Ahmad Al-Subeihi, Haifa'a Marouf Odetallah, Sanaa K Bardaweel, Raghuprasad Mailavaram,  Katharigatta N. Venugopala, Anroop B. Nair. "Synthesis and evaluation of 2, 4, 5-trisubstitutedthiazoles as carbonic anhydrase-III inhibitors." Journal of Enzyme Inhibition and Medicinal Chemistry 2020, 35(1): 1483-1490.
  19. Al-Dhubiab, B.E., Patel, S.S., Morsy, M.A., Duvva, H., Nair, A.B., Pran Kishore Deb.; Shah, J. The Beneficial Effect of Boswellic Acid on Bone Metabolism and Possible Mechanisms of Action in Experimental Osteoporosis. Nutrients 2020, 12, 3186.
  20. Nefisath, Pandikatte, Prasad D. Jagadeesh, B. Haripriya, Chopra Deepak, N. Venugopala Katharigatta, Pran Kishore Deb., M. Gleiser Raquel et al. "Synthesis, characterization and larvicidal activity of novel benzylidene derivatives of fenobam and its thio analogues with crystal insight." Journal of Molecular Structure 2020, 1226, 129386.
  21. Chitikina, S.S., Praveen B., Pran Kishore Deb.*, Raghu Prasad M., Katharigatta N. V., Anroop B.N., Bilal Al-Jaidi, and Supratik Kar "Synthesis and anthelmintic activity of some novel (E)-2-methyl/propyl-4-(2-(substitutedbenzylidene)hydrazinyl)-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidines." Medicinal Chemistry Research 2020, 1-11.
  22. Venugopala, Katharigatta N., Mohammed A. Khedr, Yarabahally R. Girish, Subhrajyoti Bhandary, Deepak Chopra, Mohamed A. Morsy, Bandar E. A., Pran Kishore Deb., et al. "Crystallography, in Silico Studies, and In Vitro Antifungal Studies of 2, 4, 5 Trisubstituted 1, 2, 3-Triazole Analogues." Antibiotics 2020, 9(6), 350.
  23. Venugopala, K.N.; Uppar, V.; Sandeep C; Abdallah, H.H.; Pillay, M.; Pran Kishore Deb.; Morsy, M.A.; Aldhubiab, B.E.; Attimarad, M.; Nair, A.B., et al. Cytotoxicity and antimycobacterial properties of pyrrolo[1,2-a]quinoline derivatives: Molecular target identification and molecular docking studies. Antibiotics 2020, 9, 1-14.
  24. Venugopala, K.N.; Ramachandra, P.; Tratrat, C.; Gleiser, R.M.; Bhandary, S.; Chopra, D.; Morsy, M.A.; Aldhubiab, B.E.; Attimarad, M.; Nair, A.B.; Sreeharsha, N.; Venugopala, R.; Pran Kishore D., et al. Larvicidal Activities of 2-Aryl-2,3-Dihydroquinazolin -4-ones against Malaria Vector Anopheles arabiensis, In Silico ADMET Prediction and Molecular Target Investigation. Molecules 2020, 25, 1316.
  25. Uppar, V., Chandrashekharappa, S., Venugopala, K.N., Pran Kishore D., et al. Synthesis and characterization of pyrrolo[1,2-a]quinoline derivatives for their larvicidal activity against Anopheles arabiensis. Structural Chemistry 2020, 31(4), 1533-1543.  
  26. Khasim S., Pran Kishore D.*, Raghuprasad M., Balakumar C., Sonja K., Karl-Norbert K., Abdulmuttaleb Y. J. 7-Amino-2-aryl/heteroaryl-5-oxo-5,8-dihydro[1,2,4]triazolo[1,5-a]pyridine-6-carbonitriles: Synthesis and Adenosine Receptor Binding Studies. Chemical Biology & Drug Design 2019, 94 (2), 1568-1573.   
  27. Pran Kishore D.*, Raghuprasad M., Balakumar C., Venkata R.K., Sonja K., Rajwinder K., Raghuram Rao A., Karl-Norbert K. Synthesis, Adenosine Receptor Binding and Molecular Modeling Studies of Novel Thieno[2,3-d]pyrimidine Derivatives. Chemical Biology & Drug Design 2018, 91(4), 962-969.
  28. Balakumar C., Pran Kishore D.*, Sonja K., Raghuram Rao A., Raghuprasad M., Karl-Norbert K. Synthesis and Adenosine Receptors Binding Studies of New Fluorinated Analogues of Pyrido[2,3-d]pyrimidines and Quinazolines. Medicinal Chemistry Research. 2018, 27, 756-767. 
  29. Balakumar C., Pran Kishore D., Raghuram Rao A. Structure-based Design and Pharmacological Study of Fluorinated Fused Quinazolines as Adenosine A2B Receptor Antagonists. JSM Chem. 2017, 5(2), 1041.
  30. Hazwanie H, David WK Chong, Er HM, Pran Kishore D, Wong PS, Lee MS, Maharajan MK, Lee EL, Baloch HZ. Student’s perceptions of live online virtual e-problem based learning (LOVE-PBL) using google hangouts. Education in Medicine Journal. 2017, 9(4), 31–39.
  31. Venkata R.K., Raghuram Rao A., Pran Kishore D., Mallikarjuna R.P. Basic Ionic Liquid [bmIm]OH–Mediated Gewald Reaction as Green Protocol for the Synthesis of 2-Aminothiophenes. Synthetic Communications 2015, 4(1), 119-126.
  32. Pran Kishore D.*, Rajwinder K., Balakumar C., Madhu B., Dilshad G., Venkata RK, Raghuram Rao A., Raghuprasad M. Synthesis, anti-inflammatory evaluation, and docking studies of some new thiazole derivatives. Medicinal Chemistry Research 2014, 23(6), 2780-2792.
  33. Mamta S.D., Pran Kishore D., Renu C., Tejvir S. Maninder K. Synthesis, evaluation and molecular docking studies of cycloalkyl/aryl-3,4,5-trimethylgallates as potent non-ulcerogenic and gastroprotective anti-inflammatory agents. Medicinal Chemistry Research 2014, 23, 87-106.
  34. Pran Kishore D.*, Dina El-R., Ahmad J., Jeyashanthini A/P N., Kulasekar A/L K., Mallikarjuna R.P. In Silico Binding Mode Analysis (Molecular Docking studies), and ADME Prediction of Some Novel Inhibitors of Aurora Kinase A in Clinical Trials. Asian Journal of Chemistry 2014, 26(18), 6221-6226.
  35. Pran Kishore D.*, Ahmad J., Dina El-R., Tan Y.H., Elham M.N., Mallikarjuna R.P. Molecular Docking Studies and Comparative Binding Mode Analysis of FDA Approved HIV Protease Inhibitors. Asian Journal of Chemistry 2014, 26(18), 6227-6232.  
  36. Pran Kishore D.*, Raghuprasad M., Raghuram Rao A., Mallikarjuna R.P. Antiinflammatory Evaluation and Docking Studies of Some New Thienopyrimidines. Asian Journal of Chemistry 2013, 25(18), 10583-10587.
  37. Pran Kishore D.*, Ajay R., Upendra K.J., Mallikarjuna R.P. Pharmacophore-Based 3D-QSAR Studies of Aromatase Inhibitors. Asian Journal of Chemistry 2013, 25(18), 10588-10594.
  38. Venkata R.K., Balakumar C., Lakshmi Narayana B., Pran Kishore D., Rajwinder K., Raghuram Rao A. Transesterification of trimethylorthoacetate: an efficient protocol for the synthesis of 4-alkoxy-2-aminothiophene-3-carbonitrile. Tetrahedron Letters 2013, 54, 1274-1278.
  39. Guillermo S.M., Rodrigo R.T., Daniel G.M., Samuel R.N., Pran Kishore D., Marta B., Francisco L.G. Docking Studies of Binding of Ethambutol to the C-Terminal Domain of the Arabinosyltransferase from Mycobacterium tuberculosis. Journal of Chemistry 2013, 601270.
  40. Pran Kishore D., Anuradha K, Poonam P., Raghuram Rao A. Molecular docking and receptor specific 3D-QSAR studies of acetylcholinesterase Inhibitors. Molecular Diversity 2012, 16, 803–823.
  41. Lakshmi Narayana B., Pran Kishore D., Balakumar C., Venkata Rao K., Rajwinder K., Raghuram Rao A., Narashima M.J., Ravikumar M. Molecular modeling evaluation of non-steroidal aromatase inhibitors. Chemical Biology & Drug Design 2012, 79, 674–682.
  42. Alka B., Ruchika O., Pran Kishore D. Synthesis, evaluation and docking studies on 3-alkoxy-4-methanesulfonamido acetophenone derivatives as non ulcerogenic anti-inflammatory agents. European Journal of Medicinal Chemistry 2012, 49, 397-405.
  43. Murty D., Pran Kishore D., Raghu Prasad M., Narsaiah B., Girija S.V. Rapid and efficient microwave-assisted, base catalyzed synthesis of some novel 2,7-disubstituted pyrrolopyrimidinones. Synthetic Communications 2012, 42(21), 3103-3111.
  44. Balakumar C., Pran Kishore D., Venkat Rao K., Lakshmi N.B., Rajwinder K., Rajkumar V., Raghuram Rao A. Design, Microwave-assisted Synthesis and In Silico Docking Studies of new 4H-pyrimido[2,1-b]-benzothiazole-2-arylamino-3-cyano-4-ones as Possible Adenosine A2B Receptor Antagonists. Indian J. Chem. 51B, 2012, 1105-1113.
  45. Upendra K.J., Richa K.B., Raghuram Rao A., Ranjit S., Pran Kishore D., Venkat Rao K. Design and synthesis of triphenyl-1H-pyrazole derivatives as anticancer agents. Int. J. Pharm. Pharm. Sci. 2012, 4, 600-04.
  46. Pran Kishore D., Balakumar C., Raghuram Rao A, Partha P.R., Kunal R. QSAR of adenosine receptor antagonists: exploring physicochemical requirements for binding of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A3 receptor subtype. Bioorganic and Medicinal Chemistry Letters 2011, 21(2), 818-823.
  47. Rajwinder K., Pran Kishore D., Lakshmi N.B., Venkat R.K., Balakumar C., Rajkumar V., Raghuram Rao A. Facile microwave-assisted synthesis of 8,9-cycloalkathieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-ones, Journal of Chemical Sciences 2011, 123(1), 69-73.
  48. Balakumar C., Lamba P., Pran Kishore D., Lakshminarayana B., Venkat Rao K., Rajwinder K., Raghuram Rao A., Shireesha B., Narsaiah B. Design, synthesis, biological evaluation and docking studies of some fluorinated fused-quinazolines as antiinflammatory agents. Eur. J. Med. Chem. 2010, 45, 4904-4913.
  49. Raghu Prasad M., Pran kishore D. Multistep, Microwave Assisted, Solvent Free Synthesis  and Antibacterial Activity of 6-Substituted-2,3,4-trihydropyrimido[1,2-c]9,10,11,12-tetrahydrobenzo[b]thieno[3,2-e]pyrimidines. Chemical and Pharmaceutical Bulletin 2007, 55(5), 776-779.
  50. Raghu Prasad M., Prashanth J., Shilpa S.K., Pran Kishore D. Synthesis and Antibacterial Activity of Some Novel Triazolothienopyrimidines. Chemical and Pharmaceutical Bulletin 2007, 55, 557-560.
  51. Raghu Prasad M., Razia S., Pran Kishore D. Microwave Assisted Synthesis of Some Novel Thiadiazolothienopyrimidines. Journal of Chemical Research 2007, 133-135.

REVIEW ARTICLES: (*Corresponding author)

  1. Hazarika, Sangeeta, Pobitra Borah, Pran Kishore Deb, Katharigatta N. Venugopala, and Siva Hemalatha. "Icacinaceae Plant Family: A Recapitulation of the Ethnobotanical, Phytochemical, Pharmacological, and Biotechnological Aspects." Current Pharmaceutical Design, 2023, 29(15), 1193-1217.
  2. Uppumavuluri, Naga Tejaswi, Sri Ram Krovvidi, Raghu Prasad Mailavaram, Sujit Kumar Mohanty, Pran Kishore Deb, and Katharigatta N. Venugopala. "Pks 13 inhibitors—a promising target for future antitubercular agents." Medicinal Chemistry Research, 2023, 1-15.
  3. Reddy Chinnappanna, N.K., Yennam, G., Chaitanya, C.B.H.N.V., Pottathil, S., Borah, P., Venugopala, K.N., Pran Kishore Deb and Raghuprasad M. Recent approaches in the drug research and development of novel antimalarial drugs with new targets. Acta Pharmaceutica, 2023; 73(1), 1-27.
  4. El-Malah, Afaf A., Magdy M. Gineinah, Pran Kishore Deb*, Ahdab N. Khayyat, Monika Bansal, Katharigatta N. Venugopala, and Anfal S. Aljahdali. Selective COX-2 Inhibitors: Road from Success to Controversy and the Quest for Repurposing. Pharmaceuticals. 2022; 15(7):827.
  5. Badr-Eldin, Shaimaa M., Hibah M. Aldawsari, Sabna Kotta, Pran Kishore Deb*, and Katharigatta N. Venugopala. Three-Dimensional In Vitro Cell Culture Models for Efficient Drug Discovery: Progress So Far and Future Prospects. Pharmaceuticals. 2022; 15(8):926.
  6. Vishal Sharma, Rina Das, Dinesh Kumar M, Sumeet G., Katharigatta N. Venugopala, Raghuprasad Mailavaram, Anroop B. Nair, Ashok K. Shakya, Pran Kishore Deb. Recent insight into the biological activities and SAR of quinolone derivatives as multifunctional scaffold. Bioorganic Medicinal Chemistry Letters, 2022 59(1), 116674.
  7. Patel, Vruti, Chitra Rajani, Vishakha Tambe, Dnyaneshwar Kalyane, Neelima Anup, Pran Kishore Deb, Kiran Kalia, and Rakesh K. Tekade. Nanomaterials assisted chemo-photothermal therapy for combating cancer drug resistance. Journal of Drug Delivery Science and Technology, 2022, 70, 103164.
  8. Shinu, Pottathil, Abdulaziz K. Al Mouslem, Anroop B. Nair, Katharigatta N. Venugopala, Mahesh Attimarad, Varsha A. Singh, Sreeharsha Nagaraja, Ghallab Alotaibi, and Pran Kishore Deb. Progress Report: Antimicrobial Drug Discovery in the Resistance Era. Pharmaceuticals 2022, 15(4), 413.
  9. Shinu, Pottathil, Mohamed A. Morsy, Anroop B. Nair, Abdulaziz K. Al Mouslem, Katharigatta N. Venugopala, Manoj Goyal, Monika Bansal, Shery Jacob, and Pran Kishore Deb. Novel Therapies for the Treatment of Neuropathic Pain: Potential and Pitfalls. Journal of Clinical Medicine. 2022; 11(11):3002.
  10. Arshad, Mohammed F., Aftab Alam, Abdullah Ayed Alshammari, Mohammed Bader Alhazza, Ibrahim Mohammed Alzimam, Md Anish Alam, Gulam Mustafa, Md Salahuddin Ansari, Abdulelah M. Alotaibi, Abdullah A. Alotaibi, Suresh Kumar, Syed Mohammed Basheeruddin Asdaq, Mohd. Imran, Pran Kishore Deb, Katharigatta N. Venugopala, and Shahamah Jomah. Thiazole: A Versatile Standalone Moiety Contributing to the Development of Various Drugs and Biologically Active Agents. Molecules. 2022; 27(13):3994.
  11. Venugopala KN, Chaudhary J, Sharma V, Jain A, Kumar M, Sharma D, Shinu P, Aldhubiab BE, Deb Pran Kishore, Alwassil OI, Attimarad M, Nair AB, Sreeharsha N, Venugopala R, Kandeel M, Tratrat C, El-Deeb W, Haroun M, Mahomoodally MF, Mohanlall V, Morsy MA. Exploring the potential of flavonoids as efflorescing antidiabetic: An updated SAR and mechanistic based approach. Phcog. Mag. 2022; 18: 791-807.
  12. Pobitra Borah, Pran Kishore Deb, Balakumar Chandrasekaran, Manoj Goyal, Monika Bansal, Snawar Hussain, Shinu Pottathil, Katharigatta Narayanaswamy Venugopala, Nizar A Al-Shar'i, Satyendra Deka, Vinayak Singh*. Neurological consequences of SARS-CoV-2 infection and concurrence of treatment-induced neuropsychiatric adverse events in COVID-19 patients: Navigating the uncharted. Frontiers in Molecular Biosciences. 2021; 8: 627723.
  13. Pobitra Borah, Pran Kishore Deb, Nizar Al-Shar'I, Lina Dahabiyeh, Katharigatta Narayanaswamy Venugopala, Vinayak Singh, Snawar Hussain, Shinu Pottathil, Satyendra Deka, Balakumar Chandrasekaran and Da'san Mahmoud Mousa Jaradat. Perspectives on RNA vaccine candidates for COVID-19. Frontiers in Molecular Biosciences. 2021; 8: 30.
  14. Noor El-huda Kh. Daoud, Pobitra Borah, Pran Kishore Deb, Katharigatta N. Venugopala*, Wafa Hourani, Muhammed Alzweiri, Sanaa K. Bardaweel, Vinod Tiwari. Perspectives of In silico, In vitro and Integrated ADMET Profiling in the Drug Discovery and Development. Current Drug Metabolism. 2021, 22(7), 503-522.
  15. Pobitra Borah, Pran Kishore Deb,* Katharigatta N. Venugopala, Nizar A. Al-Shar’i, Vinayak Singh, Satyendra Deka, Amavya Srivastava, Vinod Tiwari, Raghu Prasad Mailavaram. Tuberculosis: An Update on Pathophysiology, Molecular Mechanisms of Drug Resistance, Newer Drugs or Regimens, and Host-Directed Therapies. Current Topics in Medicinal Chemistry. 2021, 21(6): 547-570(24).
  16. Pobitra Borah, Pran Kishore Deb,* Satyendra Deka, Katharigatta N. Venugopala, Vinayak Singh, Raghu Prasad Mailavaram, Kiran Kalia, Rakesh Kumar Tekade. Current scenario and future prospect in the management of COVID-19. Current Medicinal Chemistry, 2021, 28(2): 284-307(24). 
  17. Kaur, Rajwinder, Pran Kishore Deb, Vishal Diwan, and Balraj Saini. "Heparanase Inhibitors in Cancer Progression: Recent Advances." Current Pharmaceutical Design, 2021, 27(1): 43-68(26).
  18. Sunita C., Dnyaneshwar K., Vishakha T., Pran Kishore Deb*, Kiran K., Rakesh K.T. Evolving nanoformulation strategies for diagnosis and clinical interventions for Parkinson’s disease. Drug Discovery Today. 2020, 25(2), 392-405.
  19. Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M. Badr-Eldin, Nabil Abdulhafiz Alhakamy, Shadab Md, Anroop B Nair, Pran Kishore Deb*. Combating the Pandemic COVID-19: Clinical trials, Therapies and Perspectives. Frontiers in Molecular Biosciences, 2020, 7, 336.
  20. Sabna Kotta, Hibah Mubarak Aldawsari, Shaimaa M. Badr-Eldin, Nabil Abdulhafiz Alhakamy, Shadab Md, Anroop B Nair, Pran Kishore Deb*. "Exploring the Potential of Carbon Dots to Combat COVID-19." Frontiers in Molecular Biosciences, 2020, 7, 428.
  21. Shinu, Pottathil, Mohamed A. Morsy, Pran Kishore Deb, Anroop B. Nair, Manoj Goyal, Jigar Shah, and Sabna Kotta. "SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness." Frontiers in Molecular Biosciences, 2020, 7, 439.
  22. Shaw, Sneha, Ankit Uniyal, Anagha Gadepalli, Vineeta Tiwari, Daria A. Belinskaia, Natalia N. Shestakova, Katharigatta N. Venugopala, Pran Kishore Deb, and Vinod Tiwari. "Adenosine receptor signalling: Probing the potential pathways for the ministration of neuropathic pain." European Journal of Pharmacology 2020: 889(15) 173619.
  23. Samanvai Reddy Tetali, Eswar Kunapaeddi, Raghu Prasad Mailavaram, Vinayak Singh, Pobitra Borah, Pran Kishore Deb*, Katharigatta N. Venugopala, Wafa Hourani, Rakesh Kumar Tekade. Current Advances in the Clinical Development of Anti-tubercular Agents. Tuberculosis, 2020, 125, 101989.
  24. Omar Al-Attraqchi, Pran Kishore Deb*, Noor Husham Ahmed Al-Attraqchi. Phytochemistry and Pharmacological Properties of Valeriana officinalis. Current Traditional Medicine, 2020, 6(4), 260-277.
  25. Pran Kishore Deb*, Balakumar C., Raghuprasad M., Rakesh K.T., Abdulmuttaleb Y.J. Molecular Modelling Approaches for the Discovery of Adenosine A2B Receptor Antagonists: Current Status and Future Perspectives. Drug Discovery Today. 2019 24(9), 1854-1864.
  26. Pran Kishore Deb*. Recent Updates in the Computer-Aided Drug Design Strategies for the Discovery of Agonists and Antagonists of Adenosine Receptors. Current Pharmaceutical Design. 2019, 25(7), 747-749.      
  27. Pran Kishore Deb*. Progress in the Development of Agonists, Antagonists and Allosteric Modulators of Adenosine Receptor. Current Pharmaceutical Design, 2019, 25(25), 2695-2696.
  28. Pran Kishore Deb*. Therapeutic Potentials of Adenosine Receptors: The State of The Art. Current Pharmaceutical Design, 2019, 25(26), 2789-2791.
  29. Pran Kishore Deb*, Satyendra D., Pobitra B., Sara Nidal A., Karl-Norbert K. Medicinal Chemistry and Therapeutic Potential of Agonists and Antagonists of A1 Adenosine Receptor: Current Status and Perspectives. Current Pharmaceutical Design. 2019, 25(25), 2697-2715.
  30. Altamish M., Vijaya Paul S., Rajiv D., Yogendra S., Pran Kishore Deb, Hamid A.B., Murtaza M. T. et al. Molecular signaling of G?protein?coupled receptor in chronic heart failure and associated complications. Drug Development Research 2019, 81(1), 23-31.
  31. Pobitra B., Satyendra D., Raghu Prasad M., Pran Kishore Deb. P1 Receptor Agonists/Antagonists in Clinical Trials – The Potential Drug Candidates of the Future. Current Pharmaceutical Design. 2019, 25(26), 2792-2807.   
  32. Mohammed N. Al-Qattan, Pran Kishore Deb*, Rakesh K.T. Molecular dynamics simulation strategies of designing carbon-nanotube-based targeted drug delivery. Drug Discovery Today. 2018, 23(2), 235-250.
  33. Shubhangi M., Abhimanyu P., Kaushik K., Rahul M., Pran Kishore Deb, Kiran K., Rakesh K.T. Functionalized carbon nanotubes as emerging delivery system for the treatment of cancer. International Journal of Pharmaceutics, 2018, 548 (1), 540-558.      
  34. Sara Nidal A., Pran Kishore Deb*, Fatimah Amin Y., Hiba Salim S. Herbal medication and nutraceuticals for the management of anxiety and depression. Current Psychopharmacology, 2018, 7, 129-148.
  35. Aakash D., Richa Kaur B., Ramanjot K., Sanjiv K., Upendra Kumar J., Harinder S., Sandeep B., Dinesh K., and Pran Kishore Deb* Imidazo[1,2-a]pyridine Scaffold as Prospective Therapeutic Agents. Current Topics in Medicinal Chemistry, 2017, 16 (27), 238-250.
  36. Ahmad J., Pran Kishore Deb, Ing H.O., Dina El-R., Faridah O.S., Rajakumari R. Design, Synthesis and Pharmacological Properties of Peptidomimetics. Asian Journal of Chemistry 2015, 27(9), 3137-3142. 

 
Member of Professional Bodies
  • Member (Community Associate) of the American Chemical Society (ACS). Membership No. 30237965.
Text and Reference Books

EDITORIAL ROLES: Book (1), Thematic issues (04)

  1. BOOK: Puneet Kumar Bansal and Pran Kishore Deb (Eds.) “Frontiers in Pharmacology of Neurotransmitters” 2020, Springer, ISBN 978-981-15-3555-0. https://www.springer.com/gp/book/9789811535550#aboutAuthors
  2. Guest Editor in Chief, Thematic Issue-1: Recent updates in the computer-aided drug design strategies for discovering agonists and antagonists of adenosine receptors. Current Pharmaceutical Design, 2019, 25(7), 747-749. (Impact factor: 3)       
  3. Guest Editor in Chief, Thematic Issue-2: Progress in the Development of Agonists, Antagonists and Allosteric Modulators of Adenosine Receptor. Current Pharmaceutical Design, 2019, 25(25), 2695-2696. (Impact factor: 3)   
  4. Guest Editor in Chief, Thematic Issue-3: Therapeutic Potentials of Adenosine Receptors: The State of The Art. Current Pharmaceutical Design, 2019, 25(26), 2789-2791. (Impact factor: 3)
  5. Guest Editor in Chief, Thematic Issue-4: Opportunities and Challenges of Organic Synthesis in Drug Discovery. Molecules, 2022, in press. (Impact factor: 4.4)

BOOK CHAPTERS: (*Corresponding author)

  1. Chourasiya, Ravindra Kumar, Wafa Hourani, Pran Kishore Deb, and Katharigatta N. Venugopala. "Mitotic kinesin spindle protein (KSP/Eg5 ATPase) inhibitors." In Current Molecular Targets of Heterocyclic Compounds for Cancer Therapy, Academic Press, 2024, pp. 183-200.
  2. Borah, Pobitra, Sangeeta Hazarika, Dikshya Sharma, Katharigatta N. Venugopala, Deepak Chopra, Nizar A. Al-Shar'i, Siva Hemalatha, Ashok K. Shakya, Pratap Chandra Acharya, and Pran Kishore Deb*. "Systemic and topical antifungal drugs." In Medicinal Chemistry of Chemotherapeutic Agents, Academic Press, 2023, pp. 285-315.
  3. Priyank Purohit, Pobitra Borah, Sangeeta Hazarika, Gaurav Joshi, Pran Kishore Deb*. Computational Modeling in the Development of Antiviral Agents. Kar, Supratik, and Jerzy Leszczynski, eds. Current Trends in Computational Modeling for Drug Discovery. Springer Nature, 2023., 35, 109-136.
  4. Borah, Pobitra, Sangeeta Hazarika, Mohamed A. Morsy, Manoj Goyal, Ashna Chettri, Katharigatta N. Venugopala, Viresh Mohanlall, Pratap Chandra Acharya, Pran Kishore Deb*, and Raghu Prasad Mailavaram. "Antiviral drugs and vaccines." In Medicinal Chemistry of Chemotherapeutic Agents, Academic Press, 2023, 319-359.
  5. Borah, Pobitra, Sangeeta Hazarika, Ashna Chettri, Dikshya Sharma, Satyendra Deka, Katharigatta N. Venugopala, Pottathil Shinu, Nizar A. Al-Shar’i, Sanaa K. Bardaweel, and Pran Kishore Deb*. "Heterocyclic compounds as antimicrobial agents." In Viral, Parasitic, Bacterial, and Fungal Infections, Academic Press, 2023, 781-804.
  6. Kokaz, S.F., Pran Kishore Deb*, Borah, P., Bania, R., Venugopala, K.N., Nair, A.B., Singh, V., Al-Shari, N.A., Hourani, W., Gupta, G. and Tekade, R.K. Dendrimers: Chapter 8. Properties and Applications in Biomedical Field. Nanoengineering of Biomaterials: Biomedical Applications, Wiley, 2022, Vol 2, 215-243.
  7. Bania, Ratnali, Pobitra Borah, Juti Rani Devi, Satyendra Deka, Lina A. Dahabiyeh, Wafa Hourani, Pran Kishore Deb*, Katharigatta N. Venugopala, and Gaurav Gupta. "Advancements in Translational Respiratory Research Using Nanotechnology." In Advanced Drug Delivery Strategies for Targeting Chronic Inflammatory Lung Diseases, Springer, Singapore, 2022, 45-73.
  8. Balakumar Chandrasekaran, Pran Kishore Deb, Mohammad F Bayan, Yazan Al-Bataineh, Qutaiba Ahmed Al-Khames Aga, Jaradat Da’san MM, Ashok Kumar Balaraman. Chapter 18. Nanocarriers in novel drug delivery system. In Handbook on Nanobiomaterials for Therapeutics and Diagnostic Applications. 2021, Springer, 421-437.
  9. Bania, R., Borah, P., Deka, S., Dahabiyeh, L.A., Singh, V., Al-Shar’i, N.A., Nair, A.B., Goyal, M., Venugopala, K.N., Tekade, R.K. and Pran Kishore Deb*. Current strategies in targeted anticancer drug delivery systems to brain. In Advanced Drug Delivery Systems in the Management of Cancer 2021, Academic Press, 267-280.
  10. Singh, Mahendra, Navneeta Singh, Balakumar Chandrasekaran, and Pran Kishore Deb. "Nanomaterials in nutraceuticals applications." Integrative Nanomedicine for New Therapies 2020, 405-435.
  11. Rohitas Deshmukh, Nabamita Bandyopadhyay, Sara Nidal Abed, Shantanu Bandopadhyay, Yogendra Pal, Pran Kishore Deb. Chapter-3: Strategies for pulmonary delivery of drugs. In: Rakesh Kumar Tekade (Ed.), Drug Delivery Systems: Advances in Pharmaceutical Product Development and Research Series, Vol. V, Academic Press, 2020, 85-129.
  12. Shantanu Bandopadhyay, Satish Manchanda, Akhilesh Chandra, Javed Ali, Pran Kishore Deb. Chapter-5: Overview of different carrier systems for advanced drug delivery. In: Rakesh Kumar Tekade (Ed.), Drug Delivery Systems: Advances in Pharmaceutical Product Development and Research Series, Vol. V, Academic Press, 2020, 179-233.
  13. Pran Kishore Deb,* Sara Nidal Abed, Hussam Maher, Amal Al-Aboudi, Anant Paradkar, Shantanu Bandopadhyay, Rakesh K. Tekade. Chapter-11: Aerosols in pharmaceutical product development. In: Rakesh Kumar Tekade (Ed.), Drug Delivery Systems: Advances in Pharmaceutical Product Development and Research Series, Vol. V, Academic Press, 2019, 521-577.
  14. Balakumar Chandrasekaran, Haneen Al-Joubi, Sara Samarneh, Ghadir Kassab, Pran Kishore Deb, Puneet Kumar, Bilal Al-Jaidi, Yazan Al-Thaher and Yazan Al-Bataineh.  Chapter 2.  Drug-receptor interactions. In: Puneet Kumar Bansal and Pran Kishore Deb (Eds.), Frontiers in Pharmacology of Neurotransmitters, Springer, Singapore, 2020, 31-68.
  15. Sarah Falah Kokaz, Pran Kishore Deb,* Sara Nidal Abed, Amal Al-Aboudi, Nirupam Das,  Abdulmuttaleb Yousef Jaber, Fatimah Amin Younes,  Ruba Anwar Salou,  Puneet Kumar, Katharigatta N. Venugopala, Raghu Prasad Mailavaram. Chapter 3. Pharmacology of acetylcholine and cholinergic receptors. In: Puneet Kumar Bansal and Pran Kishore Deb (Eds.), Frontiers in Pharmacology of Neurotransmitters, Springer, Singapore, 2020, 69-105.
  16. Satyendra Deka, Ratnali Bania, Pobitra Borah, Sanjib Das, Pran Kishore Deb. Chapter 6. Pharmacology of serotonin and its receptors. In: Puneet Kumar Bansal and Pran Kishore Deb (Eds.), Frontiers in Pharmacology of Neurotransmitters, Springer, Singapore, 2020, 183-212.
  17. Gaurav Gupta, Wafa Hourani, Pran Kishore Deb, Satyendra Deka, Pobitra Borah, Juhi Tiwari, Sacchidanand Pathak, Puneet Kumar.  Chapter 13. Pharmacology of endocannabinoids and its receptors. In: Puneet Kumar Bansal and Pran Kishore Deb (Eds.), Frontiers in Pharmacology of Neurotransmitters, Springer, Singapore, 2020, 415-445.
  18. Satyendra Deka, Pobitra Borah, Ratnali Bania, Sanjib Das, Pran Kishore Deb.  Chapter 19. Pharmacology of potassium channels. In: Puneet Kumar Bansal and Pran Kishore Deb (Eds.), Frontiers in Pharmacology of Neurotransmitters, Springer, Singapore, 2020, 635-681.
  19. Divya Pandit, Pran Kishore Deb, Renu Chadha. Chapter-1: Design of materials and product specifications. In: Rakesh Kumar Tekade (Ed.), Biomaterials and Bio-Nanotechnology: Advances in Pharmaceutical Product Development and Research Series, Vol. IV, Academic Press, 2019, 2-17.
  20. Neha Maheshwari, Muktika Tekade, Yashu Chourasiya, Mukesh C. Sharma, Pran Kishore Deb,* Rakesh K. Tekade. Chapter-7: Nanotechnology in tissue engineering. In: Rakesh Kumar Tekade (Ed.), Biomaterials and Bio-Nanotechnology: Advances in Pharmaceutical Product Development and Research Series, Vol. IV, Academic Press, 2019, 226-261.
  21. Neha Maheshwari, Muktika Tekade, Namrata Soni, Piyush Ghode, Mukesh Chandra Sharma, Pran Kishore Deb, Rakesh K. Tekade. Chapter-16: Functionalized Carbon Nanotubes for Protein, Peptide, and Gene Delivery. In: Rakesh Kumar Tekade (Ed.), Biomaterials and Bio-Nanotechnology: Advances in Pharmaceutical Product Development and Research Series, Vol. IV, Academic Press, 2019, 614-633.
  22. Muktika Tekade, Neha Maheshwari, Hira Choudhury, Bapi Gorain, Pran Kishore Deb, Rakesh K. Tekade, Mukesh C. Sharma. Chapter-9: Up-to-date implications of nanomaterials in dental science. In: Rakesh Kumar Tekade (Ed.), Biomaterials and Bio-Nanotechnology: Advances in Pharmaceutical Product Development and Research Series, Vol. IV, Academic Press, 2019, 302-330.
  23. Muktika Tekade, Neha Maheshwari, Susanne R. Youngren-Ortiz, Vikas Pandey, Yashu Chourasiya, Vandana Soni, Pran Kishore Deb, Mukesh C. Sharma. Chapter-13: Thiolated-Chitosan: A Novel Mucoadhesive Polymer for Better-Targeted Drug Delivery. In: Rakesh Kumar Tekade (Ed.), Biomaterials and Bio-Nanotechnology: Advances in Pharmaceutical Product Development and Research Series, Vol. IV, Academic Press, 2019, 460-489.
  24. Pran Kishore Deb,* Omar Al-Attraqchi, Johnson Stanslas, Amal Al-Aboudi, Noor Al-Attraqchi, Rakesh K. Tekade. Chapter-5: Biotechnology-based pharmaceutical products. In: Rakesh Kumar Tekade (Ed.), Biomaterials and Bio-Nanotechnology: Advances in Pharmaceutical Product Development and Research Series, Vol. IV, Academic Press, 2019, 154-189.
  25. Pran Kishore Deb,* Haifa'a Marouf Odetallah, Bilal Al-Jaidi, Raghuram Rao Akkinepalli, Amal Al-Aboudi, Rakesh K. Tekade. Chapter-11: Biomaterials and Nanoparticles for Hyperthermia Therapy. In: Rakesh Kumar Tekade (Ed.), Biomaterials and Bio-Nanotechnology: Advances in Pharmaceutical Product Development and Research Series, Vol. IV, Academic Press, 2019, 376-413.
  26. Bapi Gorain, Hira Choudhury, Manisha Pandey, Anroop B. Nair, Mohd Cairul Iqbal Mohd Amin, Nagashekhara Molugulu, Pran Kishore Deb, Pushpendra Kumar Tripathi, Sukant Khurana, Rahul Shukla, Kanchan Kohli, Prashant Kesharwani, Chapter-7. Dendrimer-Based Nanocarriers in Lung Cancer Therapy. In: Prashant Kesharwani (Ed.), Nanotechnology-Based Targeted Drug Delivery Systems for Lung Cancer, Academic Press, 2019, Pages 161-192.
  27. Pran Kishore Deb,* Sarah Falah Kokaz, Sara Nidal Abed, Balakumar Chandrasekaran, Wafa Hourani, Abdulmuttaleb Yousef Jaber, Raghu Prasad Mailavaram, Puneet Kumar,  Katharigatta N. Venugopala.  Chapter 10. Pharmacology of adenosine receptors. In: Puneet Kumar Bansal and Pran Kishore Deb (Eds.), Frontiers in Pharmacology of Neurotransmitters, Springer, Singapore, 2020, 325-359.
  28. Pran Kishore Deb,* Omar Al-Attraqchi, Abdulmuttaleb Yousef Jaber, Basant Amarji, Rakesh Kumar Tekade, Chapter-2: Physicochemical Aspects to be considered in Pharmaceutical Product Development. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press (Elsevier), 2018, 57-83.
  29. Pran Kishore Deb,* Omar Al-Attraqchi, Raghuprasad Mailavaram, Rakesh Kumar Tekade, Chapter-11: Protein and Tissue binding: Implication on Pharmacokinetic Parameters. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press (Elsevier), 2018, 371-399.
  30. Arpna Indurkhya, Mahendra Patel, Piyoosh Sharma, Sara Nidal Abed, Abeer Shnoudeh, Rahul Maheshwari, Pran Kishore Deb and Rakesh K. Tekade, Chapter-6: Influence of Drug Properties and Routes of Drug Administration on the Design of Controlled Release System. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press, 2018, 179-223.
  31. Rahul Maheshwari, Pooja Todke, Neetu Soni, Nidhi Raval, Pran Kishore Deb, Basant Amarji, N.V. Anil Kumar Ravipati and Rakesh Kumar Tekade, Chapter-7: Stability and Degradation Studies for Drug and Drug Product. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press, 2018, 225-257.
  32. Ashok K. Shakya, Belal M.O. Al-Najjar, Pran Kishore Deb, Rakesh Kumar Tekade, Chapter-8: First pass Metabolism Considerations in Pharmaceutical Product Development. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press, 2018, 259-286.
  33. Disha Mehtani, Ankit Seth, Piyoosh Sharma, Rahul Maheshwari, Sara Nidal Abed, Pran Kishore Deb, Mahavir B. Chougule and Rakesh Kumar Tekade, Chapter-9: Dissolution profile consideration in pharmaceutical product development. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press, 2018, 287-336.
  34. Shantanu Bandopadhyay, Nabamita Bandyopadhyay, Pran Kishore Deb, Chhater Singh and Rakesh Kumar Tekade, Chapter-12: Pre-formulation studies of drug substances, protein and peptides: Role in drug discovery and pharmaceutical product development. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press, 2018, 401-433.
  35. Basant Amarji, Sara Nidal Abed, Ujjal Bairagi, Pran Kishore Deb, Omar Al-Attraqchi, Anup Avijit Choudhury and Rakesh Kumar Tekade, Chapter-18: Four stages in Pharmaceutical Product Development: Preformulation, Prototype Development and Scale-up, Biological aspects, and Commercialization. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press, 2018, 637-668.
  36. Nidhi Raval, Vishakha Tambe, Rahul Maheshwari, Pran Kishore Deb, Rakesh Kumar Tekade, Chapter-19: Scale-up studies in pharmaceutical products development. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press, 2018, 669-700.
  37. Satish Manchanda, Akhilesh Chandra, Shantanu Bandopadhyay, Pran Kishore Deb and Rakesh Kumar Tekade, Chapter-22: Formulation additives used in pharmaceutical products: Emphasis on regulatory perspectives and GRAS. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press, 2018, 773-831.
  38. Yogendra Pal, Pran Kishore Deb, Shantanu Bandopadhyay, Nabamita Bandyopadhyay, Rakesh Kumar Tekade, Chapter-3: Role of physicochemical parameters on drug absorption and their implications in pharmaceutical product development. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press, 2018, 85-116.
  39. Venkat Ratnam Devadasu, Pran Kishore Deb, Rahul Maheshwari, Piyoosh Sharma, Rakesh Kumar Tekade, Chapter-5: Physico-chemical, Pharmaceutical and Biological Considerations in GIT Absorption of Drugs. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Considerations: Advances in Pharmaceutical Product Development and Research Series, Vol. I, Academic Press, 2018, 149-178.
  40. Pran Kishore Deb,* Sarah Falah Kokaz, Sara Nidal Abed, Anant Paradkar and Rakesh K. Tekade. Chapter-6: Pharmaceutical and Biomedical Applications of Polymers. In: Rakesh Kumar Tekade (Ed.), Basic Fundamentals of Drug Delivery: Advances in Pharmaceutical Product Development and Research Series, Vol. III, Academic Press, 2019, 204-255.
  41. Pran Kishore Deb,* Omar Al-Attraqchi, Balakumar Chandrasekaran, Anant Paradkar, and Rakesh K. Tekade. Chapter-16: Protein/Peptide Drug Delivery Systems: Practical Considerations in Pharmaceutical Product Development. In: Rakesh Kumar Tekade (Ed.), Basic Fundamentals of Drug Delivery: Advances in Pharmaceutical Product Development and Research Series, Vol. III, Academic Press, 2019, 652-684.
  42. Sara Nidal Abed, Pran Kishore Deb,* Hiba Salim Surchi, Sarah Falah Kokaz, Saadh Mohamed Jamal, Shantanu Bandopadhyay, Rakesh K. Tekade. Chapter-17: Nanocarriers in different preclinical and clinical stages. In: Rakesh Kumar Tekade (Ed.), Basic Fundamentals of Drug Delivery: Advances in Pharmaceutical Product Development and Research Series, Vol. III, Academic Press, 2019, 668-731.
  43. Pran Kishore Deb,* Sarah Nedal Abed, Abdulmuttaleb Yousef Jaber, Rakesh Kumar Tekade, Chapter-5: Particulate Level Properties and Its Implications on Product Performance and Processing. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Parameters: Advances in Pharmaceutical Product Development and Research Series, Vol. II, Academic Press (Elsevier), 2018, 155-220.
  44. Pran Kishore Deb,* Omar Al-Attraqchi, Mohammed Nooraldeen Al-Qattan, Raghuprasad Mailavaram, and Rakesh Kumar Tekade, Chapter-19: Applications of computers in pharmaceutical product formulation. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Parameters: Advances in Pharmaceutical Product Development and Research Series, Vol. II, Academic Press (Elsevier), 2018, 665-703.
  45. Rahul Maheshwari, Yashu Chourasiya, Shantanu Bandopadhyay, Prashant K. Katiyar, Piyoosh Sharma, Pran Kishore Deb, and Rakesh Kumar Tekade, Chapter-1: Levels of solid state properties: Role of different levels during pharmaceutical development. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Parameters: Advances in Pharmaceutical Product Development and Research Series, Vol. II, Academic Press, 2018, 1-30.
  46. Amit Bhatia, Shruti Chopra, Kalpana Nagpal, Pran Kishore Deb, Muktika Tekade, and Rakesh Kumar Tekade, Chapter-2: Polymorphism and its Implications in Pharmaceutical Product Development. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Parameters: Advances in Pharmaceutical Product Development and Research Series, Vol. II, Academic Press, 2018, 31-65.
  47. Raghu Prasad Mailavaram, Pran Kishore Deb, Balakumar Chandrashekaran, Rakesh Kumar Tekade, Chapter-3: Basics of Crystallization Process Applied in Drug Research. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Parameters: Advances in Pharmaceutical Product Development and Research Series, Vol. II, Academic Press, 2018, 67-103.
  48. Randa S.H. Mansour, Pran Kishore Deb, and Rakesh Kumar Tekade, Chapter-4: Role of Amorphous State in Drug Delivery. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Parameters: Advances in Pharmaceutical Product Development and Research Series, Vol. II, Academic Press, 2018, 105-154.
  49. Ankur Barua, Pran Kishore Deb, Rahul Maheshwari and Rakesh Kumar Tekade, Chapter-10: Statistical Techniques in Pharmaceutical Product Development. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Parameters: Advances in Pharmaceutical Product Development and Research Series, Vol. II, Academic Press, 2018, 340-359.
  50. Basant Amarji, Amol Kulkarni, Pran Kishore Deb, Deepika, Rahul Maheshwari, and Rakesh Kumar Tekade, Chapter-15: Package Development of Pharmaceutical Products: Aspects of packaging Material used in Pharmaceutical product. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Parameters: Advances in Pharmaceutical Product Development and Research Series, Vol. II, Academic Press, 2018, 521-552.
  51. Neha Taneja, Pran Kishore Deb*, Rahul Maheshwari and Rakesh Kumar Tekade, Chapter-16: Package types for different dosage forms. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Parameters: Advances in Pharmaceutical Product Development and Research Series, Vol. II, Academic Press, 2018, 553-590.
  52. Divya Pandit, Pran Kishore Deb*, and Rakesh Kumar Tekade. Chapter-20: Patents and other intellectual property rights in drug delivery. In: Rakesh Kumar Tekade (Ed.), Dosage Form Design Parameters: Advances in Pharmaceutical Product Development and Research Series, Vol. II, Academic Press, 2018, 705-730.
  53. Pran Kishore Deb,* Raghuprasad Mailabaram, Bilal Al-Jaidi, Mohamed Jamal Saadh. Chapter-6. Molecular Basis of Binding Interactions of NSAIDs and Computer Aided Drug Design Approaches in the Pursuit of the Development of Selective Cyclooxygenase-2 (COX-2) Inhibitors. In: Mohd. Gamal Ali (Ed.), "Nonsteroidal Anti-inflammatory Drugs,” ISBN 978-953-51-5380-1, InTech, 2017, 101-121. 
Intellectual Property Rights (IPR)
  1. Venugopala, Katharigatta N., Pran Kishore Deb, Buccioni Michela, Gabriella Marucci, Sandeep Chandrashekharappa, and Rashmi Venugopala. "7-isopropyl-1,2-dimethyl 3-(substituted benzoyl)indolizine-1,2,7-tricarboxylates as adenosine receptor active compounds." U.S. Patent 11981673B1, issued 14/05/2024.
  2. Venugopala, Katharigatta N., Pran Kishore Deb, Melendran Pillay, P. Nefisath, Mohamed A. Morsy, S. Shashiprabha, Jagadeesh Prasad Dasappa, and Rashmi Venugopala. "Oxoimidazolidine derivatives as anti-tubercular agents." U.S. Patent 11981643B1, issued 14/05/2024.
  3. Venugopala, Katharigatta N., Sandeep Chandrashekharappa, Pran Kishore Deb, Osama I. Alwassil, and Rashmi Venugopala. "7-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1, 7-dicarboxylates as larvicidal agents." U.S. Patent 11981674B1, issued 14/05/2024.
  4. Venugopala, Katharigatta N., Melendran Pillay, Vijaykumar Uppar, Pran Kishore Deb, Rashmi Venugopala, Sandeep Chandrashekharappa, and Basavaraj Padmashali. "Substituted 7-amino-3-(substituted benzoyl) indolizine-1-carboxylates as anti-tubercular agents." U.S. Patent 11976066B1, issued 07/05/2024.
  5. Venugopala, Katharigatta N., Buccioni Michela, Gabriella Marucci, Pran Kishore Deb, Mohamed A. Morsy, Bandar Aldhubiab, Mahesh Attimarad et al. "Adenosine receptor activity of methyl/ethyl 3-(substituted benzoyl)-6, 8-dimethylindolizine-2-substituted-1-carboxylates." U.S. Patent 11974991B1, issued 07/05/2024.
  6. Venugopala, Katharigatta N., Pran Kishore Deb, and Rashmi Venugopala. "{5-chloro-2-(2-(3-(substitutedphenyl)-1,2,4-oxadiazol-5-yl)ethyl)phenyl}(phenyl)methanones as larvicidal agents." U.S. Patent 11970470B1, issued 30/04/2024.
  7. Venugopala, Katharigatta N., Osama I. Alwassil, Pran Kishore Deb, Rashmi Venugopala, Priya R. Kadam, Yadav D. Bodke, and Vijaykumar Uppar. "4-[(substituted-1H-benzimidazol-2-ylsulfanyl)methyl]-6-substituted-2H-chromen-2-ones as larvicidal agents." U.S. Patent 11970489B1, issued 30/04/2024.
  8. Venugopala, Katharigatta N., Pran Kishore Deb, Vinuta Kamat, Rangappa Santosh, Boja Poojary, Manohar S. Kugaji, Vijay M. Kumba, Mohamed A Morsy, Bandar Aldhubiab, Mahesh Attimarad, Anroop B Nair, Nagaraja Sreeharsha. "5-(3-substitutedphenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agents." U.S. Patent 11964982B1, issued 23/04/2024.
  9. Venugopala, Katharigatta N., Pran Kishore Deb, Pramod Patil, Osama I. Alwassil, Mohamed A. Morsy, Bandar Aldhubiab, Vijaykumar Uppar, Mahmoud Kandeel, Praveen B. Managutti, and Basavaraj Padmashali. "Dimethyl-7-bromo-1-(4-substituted benzoyl)pyrrolo[1,2-a]quinoline-2,3-dicarboxylates as anti-inflammatory agents." U.S. Patent 11945819B1, issued 02/04/2024.
  10. Venugopala, Katharigatta N., Pran Kishore Deb, Melendran Pillay, Sandeep Chandrashekharappa, Mohamed A. Morsy, Bandar Aldhubiab, Mahesh Attimarad, Anroop B Nair, Nagaraja Sreeharsha, Christophe Tratrat, Sheena Shashikanth, Vijaykumar Uppar, Basavaraj Padmashali. "Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents." U.S. Patent 11938120B1, issued 26/03/2024.
  11. Venugopala, Katharigatta N., Mohamed A. Morsy, Pran Kishore Deb, Melandran Pillay, Ramasamy Durai, Madhusudana Reddy Muthukurpalya Bhojegowd, Dhakshanamurthy Thirumalai, and Viresh Mohanlall. "Substituted 1, 4-dihydropyrimidines as antitubercular agents." U.S. Patent 11932609B1, issued 19/03/2024.
  12. Venugopala, Katharigatta N., Pran Kishore Deb, Raghu Prasad Mailavaram, Nizar A. Al-Shar'i, Swastika Ganguly, Bapi Gorain, Lim Tse Mun, and Jamie Kow Kean Hing. "Thieno [2,3-d]pyrimidines as COX-2 inhibitors." U.S. Patent 11932656B1, issued 19/03/2024.
  13. Venugopala, Katharigatta N., Pran Kishore Deb, Vinuta Kamat, Rangappa Santosh, Boja Poojary, Manohar S. Kugaji, Vijay M. Kumbar, Mohamed A Morsy, Bandar Aldhubiab, Mahesh Attimarad, Anroop B Nair, Nagaraja Sreeharsha. "5-(3-substituted phenyl)-pyrimido[4,5-d]pyrimidine-2,4,7(1H,3H,8H)-trione derivatives as anticancer agents." U.S. Patent 11932649B1, issued 19/03/2024.
  14. Venugopala, Katharigatta N., Pran Kishore Deb, Rashmi Venugopala, Nizar A. Al-shar'i, Mohamed A. Morsy, and Bandar E. Aldhubiab. "4-amino-5-(4-fluoro-3-phenoxyphenyl)-4H-1,2,4-triazole-3-thiol derivatives as antifungal agents." U.S. Patent 11926602B1, issued 12/03/2024.
  15. Venugopala, Katharigatta N., Pran Kishore Deb, Melendran Pillay, Vijaykumar Uppar, Mohamed A. Morsy, Bandar Aldhubiab, Mahesh Attimarad, Anroop B Nair, Nagaraja Sreeharsha, Sandeep Chandrashekharappa, Padmashali, Basavaraj. "Substituted 7-methyl quinoline derivatives as antitubercular agents." U.S. Patent 11926627B1, issued 12/03/2024.
  16. Venugopala, Katharigatta N., Pran Kishore Deb, Melendran Pillay, Sandeep Chandrashekharappa, Mohamed A. Morsy, Bandar E. Aldhubiab, Mahesh Attimarad, Bandar E Aldhubiab, Mahesh Attimarad, Anroop B Nair, Nagaraja Sreeharsha, Vijaykumar Uppar, Raghu Prasad Mailavaram, Basavaraj Padmashali. "1-substituted benzoyl-4-bromopyrrolo [1,2-a]quinoline-3-carboxylate derivatives as antitubercular agents." U.S. Patent 11919900B1, issued 05/03/2024.
  17. Venugopala, Katharigatta N., Pran Kishore Deb, Melendran Pillay, Mohamed A. Morsy, Bandar Aldhubiab, and Sandeep Chandrashekharappa. "1-2(-(substitutedphenyl)-2-oxoethyl)-4-(isopropoxycarbonyl)pyridin-1-ium bromides as anti-tubercular agents." U.S. Patent 11919860B1, issued 05/03/2024.
  18. Venugopala, Katharigatta N., Keshab M. Bairagi, Pran Kishore Deb, Melendran Pillay, Mohamed A. Morsy, Susanta K. Nayak, Sandeep Chandrashekharappa, and Osama I. Alwassil. "(6-methyl-4-substitutedphenyl-2-oxo/thioxo-1,2,3,4-tetrahydropyrimidin-5-yl)(piperidin-1-yl)methanones as antitubercular agents." U.S. Patent 11912683B1, issued 27/02/2024.
  19. Venugopala, Katharigatta N., Pran Kishore Deb, Wafa Hourani, P. Nefisath, Mohamed A. Morsy, S. Shashiprabha, Jagadeesh Prasad Dasappa, Rashmi Venugopala, and Raghu Prasad Mailavaram. "Benzylidene derivatives of fenobam as anti-inflammatory agents." U.S. Patent 11905279B1, issued 20/02/2024.
  20. Venugopala, Katharigatta N., Pran Kishore Deb, Melendran Pillay, Sandeep Chandrashekharappa, Mohamed A. Morsy, Bandar Adlhubiab, Mahesh Attimarad, Anroop B Nair, Nagaraja Sreeharsha, Christophe Tratrat, Sheena Shashikanth. "Substituted phenyl quinolin-l-ium bromide derivative as anti-tubercular agents." U.S. Patent 11884631B1, issued 30/1/2024.
  21. Venugopala, Katharigatta N., Pran Kishore Deb, Vinuta Kamat, Rangappa Santosh, Boja Poojary, Manohar S. Kugaji, Vijay M. Kumbar, Mohamed A. Morsy, Bandar Aldhubiab, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha. "5-(substitutedphenyl)-7-imino-7,8-dihydropyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione analogues as anti-inflammatory agents." U.S. Patent 11884677B1, issued 30/1/2024.
  22. Pran Kishore Deb, Ruba Anwar Salou, Wafa Hourani, Abdulmuttaleb Jaber Yousef. “2-4-Disubstituted-thieno[2,3-d]pyrimidine derivatives and uses thereof.” WIPO Patent No. WO2023/281552 A1, issued 12/01/2023.   
  23. Venugopala, Katharigatta N., Pran Kishore Deb, Melendran Pillay, Sandeep Chandrashekharappa, Mohamed A. Morsy, Bandar Aldhubiab, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Christophe Tratrat, Sheena Shashikanth, Vijaykumar Uppar, Basavaraj Padmashali. "Ethyl 2-substituted-1-(substitutedbenzoyl)-7-methylpyrrolo[1,2-a]quinoline-3-carboxylate derivatives as anti-tubercular agents." U.S. Patent 11845746B1, issued 19/12/2023.
  24. Venugopala, Katharigatta N., Bandar Aldhubiab, Mohamed A. Morsy, Mahesh Attimarad, Anroop B. Nair, Nagaraja Sreeharsha, Christophe Tratrat, Sandeep Chandrashekharappa, Melendran Pillay, Pran Kishore Deb, Shashikanth, S. "7-isopropyl 1-ethyl/methyl 3-(substituted benzoyl)-2-substituted indolizine-1,7-dicarboxylates as anti-tubercular agents." U.S. Patent US11807640B1, issued 77/11/2023.
  25. Venugopala, Katharigatta N., Attimarad, Mahesh, Anroop B. Nair, Nagaraja Sreeharsha, Mohaed A. Morsy, Sandeep Chandrashekharappa, Melendran Pillay, Pran Kishore Deb. “Antitubercular Compounds.” U. S. Patent  US11530217B1, issued 20/12/2022.    
  26. Mailavaram Raghu Prasad, Devarakonda SSGPMVR Murty, Vedula Girija Sastry, Shaik Khasim, Pran Kishore Deb. “7-Benzyl-4-hydrazinyl-5,6-dimethyl-2-propyl-7H-pyrolo[2,3-d]pyrimidine as potent antimycobacterial agent.” Indian Patent No. 304256, issued 10/12/2018.
Member, Editorial Board